Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

IVA vs JBIO: stock comparison and AI forecast

Inventiva S.A. (IVA) and Jade Biosciences, Inc. (JBIO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

IVA Inventiva S.A.

Price
$4.03 -25.6% · 6M
Market Cap
$939M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

JBIO Jade Biosciences, Inc.

Price
$14.06 -42.4% · 6M
Market Cap
$894M
P/E Ratio
–
Size
small-cap
AI Forecast
NO CURRENT FORECAST
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-10-30

Six-month price performance

Closing prices rebased to 100 at the start of the window.

607590105
IVA -25.6% JBIO -42.4%
IVA · JBIO

Key facts

  • IVA and JBIO have similar market capitalizations ($939M and $894M).
  • Over the last six months IVA returned -25.6% and JBIO -42.4%.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricIVAJBIO
Market Cap$939M$894M
P/B Ratio–2.03x
EPS–$-3.00
Book Value/Share–$6.92
Revenue/Share$0.09–

Profitability & Margins

MetricIVAJBIO
ROE–-42.9%
ROA–-40.0%
ROIC–-41.9%
Operating Margin-1040.1%–
Net Margin-1034.0%–
Tax Rate–-0.1%

Financial Health

MetricIVAJBIO
Current Ratio–14.93x
D/E Ratio–0.07x
Financial Leverage–1.07x
Working Capital–$440M

Cash Flow

MetricIVAJBIO
Operating Cash Flow-$182M-$124M

Income Statement

MetricIVAJBIO
Total Revenue$20M–
Operating Income-$210M-$185M
Net Income-$209M-$189M
R&D Expense$202M$157M

Dividend & Shareholder Information

MetricIVAJBIO
Shares Outstanding233M64M
FAQ

IVA vs JBIO: stock comparison and AI forecast

Which is bigger, IVA or JBIO?

IVA and JBIO have similar market capitalizations ($939M and $894M).

Which stock performed better over the last six months, IVA or JBIO?

Over the last six months IVA returned -25.6% and JBIO -42.4%.

Which one does Intratio's AI model rank higher, IVA or JBIO?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.